Talanx (ETR:TLX) Stock Price Down 1% - Should You Sell?

Key Points

• Price and volume move: Shares fell 1% to €115.20 (intraday low €114.80) on Monday, with trading volume of 86,308 shares, about 38% below the average session volume.
• Valuation and technicals: Talanx has a market cap of $30.28 billion, a P/E of 15.99, PEG of 1.66 and beta of 0.35, and trades above its 50‑day (€108.85) and 200‑day (€109.38) simple moving averages.
• Business profile: Talanx is a global insurance and reinsurance group offering a broad mix of property, casualty, life, specialty and bancassurance products.

Shares of Talanx AG (ETR:TLX - ) fell 1% during trading on Monday . The stock traded as low as €114.80 and last traded at €115.20. 86,308 shares traded hands during trading, a decline of 38% from the average session volume of 138,773 shares. The stock had previously closed at €116.40.

Talanx Stock Performance

The stock's fifty day simple moving average is €108.85 and its two-hundred day simple moving average is €109.38. The company has a market cap of $30.28 billion, a price-to-earnings ratio of 15.99, a price-to-earnings-growth ratio of 1.66 and a beta of 0.35.

About Talanx

Talanx AG provides insurance and reinsurance products and services worldwide. It offers life, casualty, liability, motor, aviation, legal protection, fire, burglary and theft, water damage, plate glass, windstorm, comprehensive householders, comprehensive home-owners, hail, livestock, engineering, omnium, marine, business interruption, travel assistance, aviation and space liability, financial lines, and other property insurance, as well as coverage for fire and fire loss of profits insurance. The company also provides bancassurance products; unit-linked life insurance, annuity and risk insurance, and long term and occupational disability insurance products; and personal accident insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.